Mrv1909 05201915192D 19 20 0 0 0 0 999 V2000 3.5330 -2.0617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2475 -1.6492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.9620 -2.0617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.6764 -1.6492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.3909 -2.0617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.1054 -1.6492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.8198 -2.0617 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 8.5343 -1.6492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.6206 -0.8287 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 9.4275 -0.6572 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 9.8400 -1.3716 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 9.2880 -1.9847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.4595 -2.7917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.2441 -3.0466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.4157 -3.8536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.8026 -4.4056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.0180 -4.1507 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 8.4049 -4.7027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.8464 -3.3437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 4 5 1 0 0 0 0 5 6 1 0 0 0 0 6 7 1 0 0 0 0 7 8 1 0 0 0 0 8 9 2 0 0 0 0 9 10 1 0 0 0 0 10 11 1 0 0 0 0 11 12 2 0 0 0 0 8 12 1 0 0 0 0 12 13 1 0 0 0 0 13 14 2 0 0 0 0 14 15 1 0 0 0 0 15 16 1 0 0 0 0 16 17 1 0 0 0 0 17 18 1 0 0 0 0 17 19 1 0 0 0 0 13 19 1 0 0 0 0 M END > DB15357 > drugbank > CCCCCCOC1=NSN=C1C1=CCCN(C)C1 > InChI=1S/C14H23N3OS/c1-3-4-5-6-10-18-14-13(15-19-16-14)12-8-7-9-17(2)11-12/h8H,3-7,9-11H2,1-2H3 > JOLJIIDDOBNFHW-UHFFFAOYSA-N > C14H23N3OS > 281.42 > 281.156183547 > 4 > 42 > 32.5535461986337 > 1 > 0 > 0 > 1 > 5-[4-(hexyloxy)-1,2,5-thiadiazol-3-yl]-1-methyl-1,2,3,6-tetrahydropyridine > 3.76 > 3.768544550666667 > -3.57 > 0 > 2 > 0 > 6.696646764982575 > 38.25000000000001 > 81.7262 > 7 > 1 > 7.58e-02 g/l > (2R)-14-fluoro-2-methyl-6,9,10,19-tetraazapentacyclo[14.2.1.0^{2,6}.0^{8,18}.0^{12,17}]nonadeca-1(18),8,12(17),13,15-pentaen-11-one > 1 > DB15357 > investigational > Xanomeline > Xanomeline $$$$